Our results demonstrated that targeted methylation of RSPO3 significantly increased TFK1 tumor volume (Fig. 5A), which also resulted in accelerated tumor growth and increased weight (Fig. 5B, C). The gene discussed is RSPO3; the disease is neoplasm.